We are live on ! Find out more
HTC

Haverford Trust Company Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.64%
This Fund
S&P 500
This Quarter Est. Return
+7.18%
1 Year Est. Return
+18.64%
3 Year Est. Return
+50.3%
5 Year Est. Return
+61.01%
10 Year Est. Return
+206.86%
AUM
$5.42B
AUM Growth
+$355M
Cap. Flow
+$24M
Cap. Flow %
0.44%
Top 10 Hldgs %
32.28%
Holding
309
New
18
Increased
89
Reduced
125
Closed
10

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$21.2M
2
KHC icon
Kraft Heinz
KHC
+$19.7M
3
KMB icon
Kimberly-Clark
KMB
+$11.4M
4
AAPL icon
Apple
AAPL
+$2.64M
5
AMZN icon
Amazon
AMZN
+$2.07M

Sector Composition

Rank Sector Weight
1 Healthcare 14.63%
2 Technology 13.57%
3 Financials 11.06%
4 Industrials 8.05%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GM icon
301
General Motors
GM
$77.2B
-5,145
Closed -$203K
HPE icon
302
Hewlett Packard
HPE
$72.4B
-14,320
Closed -$209K
KYN icon
303
Kayne Anderson Energy Infrastructure Fund
KYN
$2.45B
-13,199
Closed -$249K
VEU icon
304
Vanguard FTSE All-World ex-US ETF
VEU
$69.9B
-7,152
Closed -$371K
VNQI icon
305
Vanguard Global ex-US Real Estate ETF
VNQI
$3.52B
-4,385
Closed -$255K
STI
306
DELISTED
SunTrust Banks, Inc.
STI
-3,052
Closed -$201K

Similar funds

Haverford Trust Company's Q3 2018 Portfolio in Review

As of Q3 2018, Haverford Trust Company held 309 positions worth $5.42B, up 7% from $5.06B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Haverford Trust Company's Q3 2018 filing shows 18 new, 89 increased, 125 reduced and 10 closed positions. Its largest new stake was Sierra Wireless: 100,000 shares worth $2.01M. The largest sale was GSK, an estimated $21.2M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

  • Haverford Trust Company's largest Q3 2018 buy was Sierra Wireless: 100,000 shares worth $2.01M.
  • Haverford Trust Company added most to Qualcomm in Q3 2018, an estimated $23M increase.
  • Haverford Trust Company's biggest Q3 2018 reduction was GSK, cutting an estimated $21.2M.
  • Haverford Trust Company fully exited ANI Pharmaceuticals in Q3 2018, selling an estimated $818K.
  • Haverford Trust Company's ten largest holdings make up 32% of its $5.42B portfolio in Q3 2018.
  • Haverford Trust Company opened 18 new positions and closed 10 in Q3 2018.
  • Haverford Trust Company's portfolio value rose 7% quarter-over-quarter to $5.42B.

Based on Haverford Trust Company's 13F filing for Q3 2018, filed 8 Nov 2018.